ArticlePDF Available

Delayed Haematuria after Percutaneous Nephrolithotripsy and its Management

Authors:

Abstract and Figures

Objective: To evaluate the risk factors and management of patients developed delayed haematuria after Percutaneous nephrolithotripsy (PCNL). Methods: Data taken from 75 patients, who underwent PCNL procedures between January 2013 to June 2017. Among them 53 were male, 22 were female. Five patients presented with delayed haematuria. They were hospitalized and initially managed conservatively by bed rest and conservative treatment. Diagnostic imaging with ultrasound and non-contrast abdominal CT and serial follow up with blood tests were carried on. Angiography was performed, if indicated, to evaluate and treat possible vascular injury. All affected patients had risk factors for haematuria. Out of five, four patient had angiography, in two patients it confirm vascular injury and treated accordingly, while two were normal and one refuse for angiography. Conclusion: Delayed hematuria is one of rare and serious outcome of PCNL, but can be safely managed without serious consequences. Mostly it is secondary to vascular complication e.g., pseudo aneurysms. Presence of risk factors increases chance of haematuria. Conservative treatment is effective. In responders angiography; and embolization can be done, whenever indicated.
Content may be subject to copyright.
Delayed Haematuria after Percutaneous Nephrolithotripsy and its
Management
Naresh Kumar Valecha1*, Fariborz Bagheri2, Salam Al Hassani3, Abdulmunem Al Sadi4, Rafe souliman5
1Specialist Urologist, Dubai hospital, Albaraha, Opposite Abuhail post office, Dubai
2Consultant and head of department urology, Dubai hospital, Dubai
3Consultant department of urology, Dubai hospital, Dubai
4Senior specialist urology, Dubai hospital, Dubai
5Specialist urology, Dubai hospital, Dubai
*Corresponding author: Naresh Kumar Valecha, Specialist Urologist, Dubai hospital, Albaraha, Opposite Abuhail post office, Dubai, Tel: 923332081001; E-mail:
drnaresh_valecha@yahoo.co.in
Received date: July 01, 2017; Accepted date: August 21, 2017; Published date: August 29, 2017
Copyright: © 2017 Valecha NK, et al. This is an open-access article distributed under the terms of the creative commons attribution license, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Objective: To evaluate the risk factors and management of patients developed delayed haematuria after
Percutaneous nephrolithotripsy (PCNL).
Methods: Data taken from 75 patients, who underwent PCNL procedures between January 2013 to June 2017.
Among them 53 were male, 22 were female. Five patients presented with delayed haematuria. They were
hospitalized and initially managed conservatively by bed rest and conservative treatment. Diagnostic imaging with
ultrasound and non-contrast abdominal CT and serial follow up with blood tests were carried on. Angiography was
performed, if indicated, to evaluate and treat possible vascular injury. All affected patients had risk factors for
haematuria. Out of five, four patient had angiography, in two patients it confirm vascular injury and treated
accordingly, while two were normal and one refuse for angiography.
Conclusion: Delayed hematuria is one of rare and serious outcome of PCNL, but can be safely managed without
serious consequences. Mostly it is secondary to vascular complication e.g., pseudo aneurysms. Presence of risk
factors increases chance of haematuria. Conservative treatment is effective. In responders angiography; and
embolization can be done, whenever indicated.
Keywords: Delayed haematuria; Percutaneous nehrolithotripsy;
Pseudo aneurysm; vascular injury
Introduction
As the appraisal of open stone surgery began to reach its peak,
advancement continued in the development of less invasive techniques
for accessing renal stones. While the rst PCN was performed by
omas Hillier in 1865, Willard Goodwin in 1955 published his work
on PCN for hydronephrosis, that it gained acceptance. More than 20
years later [1-3] this example led to the recognition that the same
access could also be used as a working channel, resulting in the
percutaneous removal of a kidney stone. Over the past 30 years, PCNL
has largely replaced open renal surgery for the management of large
kidney stone [4].
It has since evolved and been rened with the development of
purposely designed instruments, endoscopes and accessories, and has
remained a standard treatment for dierent varieties of renal stones
since the eighties [5]. Compared to open renal surgery, PCNL is
associated with shorter hospital stays and allows the patient an earlier
return to work and activities of daily living. Furthermore, as PCNL is
both less invasive and less expensive to perform than open procedures,
it has become the treatment method of choice for large renal calculi
[6]. Acute hemorrhage is the most common signicant complication of
percutaneous access into the upper urinary tract collecting system.
PCN alone results in haemorrhage requiring transfusion in 0.5% to 4%
of procedures [7-9] With the addition of percutaneous
nephrolithotripsy, likely owing to the larger caliber of the percutaneous
tract and increased intrarenal manipulation, the incidence of
hemorrhage to the point of transfusion rises to 6% to 20% [10-14].
Postoperative haemorrhage can occur with the nephrostomy tube in
place, at time of tube removal, or aer discharge from the hospital.
About 1% of patients having percutaneous renal surgery are
complicated by delayed haemorrhage requiring treatment [15-17]
Delayed haemorrhage is usually due to vascular complication, e.g.:
arteriovenous stulas or arterial pseudo aneurysms,with the latter
being more common. Arterial pseudoaneurysm arises from a
transected or punctured artery that leaks in to a contained Hematoma
cavity.
is complication is likely to happen because of an artery transected
partially or end on during percutaneous nephrolithotomy puncture,
which could subsequently bleed in to contained space. is transected
arterial branch may be either partially thrombosed or in spasm
initially, leading to its non-recognition in the operating room ,as the
patient increases his /her activity ,the occluding clot may possible get
dislodged, accounting for the delayed occurrence of haematuria [18].
Valecha et al., Med Sur Urol 2017, 6:3
DOI: 10.4172/2168-9857.1000189
Research Article Open Access
Med Sur Urol, an open access journal
ISSN:2168-9857
Volume 6 • Issue 3 • 1000189
M
e
d
i
c
a
l
&
S
u
r
g
i
c
a
l
U
r
o
l
o
g
y
ISSN: 2168-9857
Medical & Surgical Urology
Methods
Data from 75 patients, who underwent PCNL procedures between
January 2013 to June 2017 and developed delayed hematuria, were
retrospectively reviewed and included in our study. Selection criteria
for PCNL was stone size ≥ 2 cm in adult patients. Children, patients
with active infection and bleeding disorders were not included in
study.
Preoperative patient evaluation included history, clinical
examination, serum creatinine level, complete blood count,
coagulation prole. All patients who have urinary tract infections were
treated according to their culture sensitivity. Patients who were taking
aspirin or other anticoagulants were stopped a week before.
All patients were evaluated with contrast enhances computed
tomography (CT) before the procedure. All procedures were
performed in prone position aer insertion of ureteric catheter.
Percutaneous renal access was established under C-arm uoroscopic
guidance through the poster lateral plane of the kidney by Urologist.
Dilatation of tract was performed by serial Aalken dilators
technique. Stones were removed following fragmentation with an
ultrasonic lithotripter and a nephrostomy tube was placed at the end of
the procedure. Aer 48 hours antegrade pyelography was done and
nephrostomy tube removed aer conrming patency and absence of
signicant residual stone.
e patients were discharged next day of nephrostomy removal, if
there were no complications.
Overall, a total of ve patients presented and were admitted in our
department with delayed intermittent haematuria following PCNL
procedures. Initially, patients were managed conservatively by bed rest,
bladder clots removal and irrigation, IV Fluid, antibiotics with
diagnostic imaging ultrasound and non-contrast abdomen CT and
serial follow up with blood tests.
Angiography was performed in selected cases to evaluate and treat
possible AV malformation. All patients characteristics, including age,
sex, stone size, operation time, number of renal accesses, access site
(subcostal or supracostal), calyx punctures, and number of blood
transfusions were recorded.
See Table 1 for patient demographic (Figures 1 and 2).
Figure 1: Sex distribution.
Figure 2: patients with delayed haematuria.
Results
Among all, 53 were male and 22 were female. Five patients (6.6%),
out of 75 patients, had delayed haematuria, and only in two patients
(2.66%) vascular injury was conrmed. All ve patients were male and
one patient had malrotated kidney. All patients, who developed this
complication, had comorbidities. Mean age of patient was 47.8 years.
Average stone size in longest diameter was 2.95(2-5 cm). Out of ve
patients; four were known hypertensive, controlled by medicines.
Average time for onset of hematuria was 13.2 days.
Four patients, those who have angiography, in two patients it was
unremarkable and in one patient it showed pseudo aneurysm,
therefore super selective angio embolization was done. He did well
initially, hematuria was settled but aer two days, gradually it started
again. It leads to clots formation in renal pelvis followed by renal
impairment. His other kidney was also relatively small, therefore we
did ureteroscopic clots removal and stenting, but unfortunately he
developed big renal hematoma and severe sepsis that necessitated
nephrectomy as life saving measure. Another patient, angiography
conrm vascular injury and leak, it was treated by balloon angioplasty.
Another patient that has extensive urolithiasis with CKD and
Hypertension and solitary functioning kidney. His angiography was
normal. We did for him cystoscopy and stenting earlier on admission
due to renal impairment. During course of conservative management
he develops sepsis. We replace stent and continue supportive
treatment, including hemodialysis, so he recovered well and
discharged. One patient who present on 5th post op day, he also bleed
during primary surgery for PCNL, so procedure was abandoned.
Bleeding was controlled by nephrostomy insertion. He didn’t require
transfusion either during or in peri- operative period. His angiography
was also normal. He had Hypertension, hyperuricemeia and .treated
for lymphoma about 10yrs before. One patient was admitted for
delayed hematuria on 8th post op day, He had Diabetes Mellitus,
Hypertension, HBsAG +VE, Glaucoma, and refuse for angiography.
He was managed with conservative treatment. Only two patients
whose angiography was positive needs blood transfusion, rest were
treated conservatively without signicant drop in hemoglobin.
Citation: Valecha NK, Bagheri F, Hassani S, Sadi A, Souliman R (2017) Delayed Haematuria after Percutaneous Nephrolithotripsy and its
Management. Med Sur Urol 6: 189. doi:10.4172/2168-9857.1000189
Page 2 of 5
Med Sur Urol, an open access journal
ISSN:2168-9857
Volume 6 • Issue 3 • 1000189
Discussion
In era of endourology and minimally invasive surgery PCNL is
standard treatment of large renal stones, as it is safe and ecient.
However minor to major complications can occurs during and aer
surgery [19-22].
Bleeding is one of most common complications. Fortunately
majority of these are minor and self-limiting and managed
conservatively but some time it necessitate the intervention.
Haemorrhage related to PCNL has reported incidence varies from
0.8% to 7.6% [23-26]. In our study we observe delayed haematuria in
ve patients that is about 6.6% and only two patients prove vascular
injury that is only 2.66%.
As kidney has got very high blood ow, 25% of cardiac output.
Some bleeding is natural with the procedure. While it requires
transfusion in 3% to 25% of cases PCNL [27-29]. Venous bleeding can
usually be controlled with nephrostomy insertion, while severe arterial
bleeding requires angiography and selective angioembolization.
Reported incidence is 0.3-1.4% [30,31] that is slight higher in our
study, and result may vary in larger scale study with increased number
of patients. Excessive bleeding usually arises from injury of segmental
arteries, which are surrounded by dense renal parenchyma, thus easier
to temponade with nephrostomy sheath or tube [32].
Patients
number
Age
(years)
Sex Stone
burden
Co-morbids Access
site and
number
Urinary
anomaly
Operation
Time
(minutes)
Occurrence of
post op
hematuria
Angiography Management
1. 68 yrs M Right
Staghorn
2.5 -2 cm
1.Hypertension
2.hyperuricemeia
3.treated for
lymphoma 2006
Middle
calyx
nil 95min/
procedure
abandoned
due to
bleeding
5th post op day Normal Conservative
2. 31 yrs M Right
Forgotten
stent +stag
horn stone 5
× 4 cm
1.Hypertensive
2.CKD
3.Bilateral renal
stone, left small
kidney
Lower pole Nil 120 min 01 month
Restart after a
week
Normal Initially
conservative
Cystoscopy
+stenting due to
sepsis and clots
removal
3. 43 M Left renal
stone 2.6 ×
1.4 cm
DM,HTN
HBsAG +VE
Glaucoma
Middle
calyx
Left mal
rotated
kidney
+partial
duplex
system
100 min 08 days Not done
(patient
refuse)
Conservatively
4 27 M Right renal
stone
+forgoten
stent
+ureteric
stones
(multiple
calculi)
Recurrent stone
former, left
kidney relatively
small, CKD
Lower
calyx
Nil 150 min 16 days angiography
reveal lower
pole pseudo
aneurysm so
embolization
performed
Cystoscopy+clots
Evacuation and
stenting due to
elevated critinine.
Blood transfusion.
5 70 M Bilateral
renal stone.
1.2 cm in
right kidney
2.5 cm left
kidney
Hypertensive,IH
D
Middle
calyx
Nil 160min 7 days Angiography
reveal
vascular
injury,treated
by baloom
angioplasty
Conservative /
supportive with
blood transfusion.
Table 1: Patients Demographic.
e Bleeding can occur during renal puncture, tract dilatation, and
manipulation of nephroscope or in post-operative period [33]. Patients
with arteriosclerosis of renal artery branches accelerated by aging,
hypertension, or diabetes mellitus are presumably are at higher risk of
bleeding. Arteriosclerosis may impair the ability of self-healing
properties of arterial wall because of loss of normal muscle and elastic
layers. Bleeding tendency is frequently noted in patients with uremia
and liver cirrhosis and those under anti-coagulant agent treatment.
Kidneys those have had retroperitoneal inammation from renal
infection and xed in the retro peritoneum are specially at higher risks
of parenchymal trauma during percutaneous intrarenal surgery [34].
Published data suggests that patient age, ASA grade, stone burden and
operation duration are associated with increased risk of vascular
complications [35]. Kessarris .et al reported in his study of 2200 PCNL,
that age, gender, medical illness, stone burden, number of renal
punctures, and procedure duration were not risk factors [36]. In our
study, all patients has some risk factors. In one patent hematuria
couldn’t settled with angioembolization, leads to severe sepsis and
nephrectomy.
Citation: Valecha NK, Bagheri F, Hassani S, Sadi A, Souliman R (2017) Delayed Haematuria after Percutaneous Nephrolithotripsy and its
Management. Med Sur Urol 6: 189. doi:10.4172/2168-9857.1000189
Page 3 of 5
Med Sur Urol, an open access journal
ISSN:2168-9857
Volume 6 • Issue 3 • 1000189
Nephrectomy related to PCNL is rare but reported in literature.
Kernohan et al reported a case of complete embolization of renal artery
which resulted in loss of kidney. Selective embolization was not
successful due to abnormal arteries which made it impossible to
embolize the feeding artery selectively [37] Stephen R, et al
[38]reported nephrectomy due to cardiovascular instability secondary
to haemorrhage [35]. Another study from Pakistan reported
nephrectomy due to massive delayed bleeding aer PCNL, due to
unavailability of interventional radiology facilities [38].
Transfusion requirement inuenced by many factors, including
operative techniques, surgeons experience, stone complexity, and
patient status. Lam et al reported that improved skills and the presence
of exible nephroscope decreased rate of blood transfusions.
In some studies it was reported that multiple parenchyma punctures
were associated with vascular injuries and increased blood
transfusions.
El-Nahas et al. [28] observed that stag horn stones and upper calyx
punctures were signicant risk factor for severe bleeding. All patients,
who presented with delayed haematuria have complex stone disease
along with co morbid risk factors. Mean operation time was 116.25
minutes, all patients were approached by lower calyx.
In our study we did angiography in 4 patients, two have normal
angiography and one patient showed Pseudoaneurysm ,therefor
embolization was done ,but that didn’t works, and he start hematuria
in 48hrs in same admission and end up with nephrectomy due sepsis
and hemodynamic instability. El-Nahas et al. [28] reported that success
rate of controlling the bleeding aer PCNL was 92.3% and 72.3% of
patients were successfully treated with single session without any
complication. is study suggest that about 28% failure of
angioembolization, this may be similar to our study ,where one patient
re start bleeding that end up with lifesaving nephrectomy. is is
similar to literature. Limitations of our study were low number of
patients and retrospective study. Probably, a multicentric prospective
study can result in a more precise outcome.
Conclusions
Delayed haematuria is one of rare and serious outcome of PCNL,
mostly It is secondary to vascular complication e.g., pseudo
aneurysms. Presence of risk factors increases chances of haematuria.
Conservative treatment is eective and still the treatment option.
Angiography can be an option for non-responder with possible
embolization if indicated.
References
1. Wen CC, Nakada SY (2007) Treatment selection and outcomes: renal
calculi. Clin North Am 34: 409-419.
2. Bloom DA, Morgan RJ, Scardino PL (1989) omas Hillier and
percutaneous nephrostomy. Urology 33: 346-350.
3. Goodwin WE, Casey WC, Woolf W (1955) Percutaneous trocar (needle)
nephrostomy in hydronephrosis. J Am Med Assoc 157: 891-894.
4. Deane LA, Clayman RV (2007) Advances in percutaneous
nephrostolithotomy. Urol Clin North Am 34: 383-395.
5. Bill T (2009) Percutaneous Nephrolithotomy. Medical Bulletin 10:14-17.
6. Chao D, Abdulla AN, Kim S, Hoogenes J, Matsumoto ED (2014) A Novel
Endoscopic Treatment for renal arteriopelvic stula post-percutaneous
nephrolithotomy (PCNL). Int Braz J Urol 40: 568-573.
7. Radecka E, Magnusson A (2004) Complications associated with
percutaneous nephrostomies. A retrospective study. Acta Radiol 45:
184-188.
8. Wah TM, Weston MJ, Irving HC (2004) Percutenous Nephrostomy
Insertion:outcome data from prospective multi-opertor study at a UK
training center. Clin Radiol 59: 255-261.
9. ACR (2007) Practice guidelines for the performance of percutenous
nephrostomy in ACR practice guide lines and technical standards
Reston(VA)American College Of Radiology 705-715.
10. Kukreja R, Desai M, Patel S, et al. (2004) Factors aecting blood loss
during percutenous lithotomy: prospective study . J Endourol 18:
715-722.
11. Netto NR Jr, Ikonomidis J, Ikari O, Claro JA (2005) Comparative study of
percutaneous access for staghorn calculi. Urology 65: 659-662.
12. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, et al.
(2005) AUA guideline on management of staghorn calculi: diagnosis and
treatment recommendations. J Urol 173: 1991-2000.
13. Muslumanoglu AY, Tefekli A, Karadag MA, Tok A, Sari E, et al. (2006)
Impact of percutaneous access point number and location on
complication and success rates in percutaneous nephrolithotomy. Urol Int
77: 340-346.
14. Chew BH, Chiu RY, Hamidizadeh R, Wright I, Chan SH, et al. (2009)
Success and complication rate in 729 percutaneous nephrolithotomies at
single center. J Urol 181: 493-494.
15. Kessaris DN, Bellman GC, Pardalidis NP, Smith AG (1995) Management
of hemorrhage aer percutaneous renal surgery. J Urol 153: 604-608.
16. Martin X, Murat FJ, Feitosa LC, Rouvière O, et al. severe bleeding aer
nephrolithotomy: results of hyperselective embolization. Eur Urol
37:136-139.
17. Richstone L, Reggio E, Ost MC, Seideman C, Fossett LK, et al. (2008)
Hemorrhage following percutaneous renal surgery: Characterization of
angiographic ndings. J Endourol 22:1129-1135.
18. Vijay MK, Vijay P, Das RK, Kundu AK (2011) Renal artery
pseudoaneurysm following percutaneous nephrolithotomy. Saudi J
Kidney Dis Transpl 22: 347-348.
19. Jinga VB, Youssef S, Radavoi GD, Braticevici B, Filipoiu M (2013)
Balgradean.Transarterial Embolization of Renal Vascular Lesions aer
Percutaneous Nephrolithotomy. Chirurgia 108: 521-529.
20. Ritter M, Krombach P, Michel M (2011) Percutaneous Stone Removal.
Eur Urol 10: 433-439.
21. Geavlete P, Mulţescu R, Geavlete B (2012) Endoscopic surgery for
urolithiasis: what does "stone free" mean in 2012. Chirurgia (Bucur) 107:
693-696.
22. Geavlete P, Mulaescu R, Jecu M, Georgescu D, Geavlete BP (2009)
Percutaneous approach in the treatment of matrix lithiasis. Experience of
the urological department of "Saint John" Emergency Clinical Hospital.
Chirurgia (Bucur) 104: 447-451.
23. Skolarikos A, Alivizatos G, de la Rosette JJ (2005) Percutaneous
nephrolithotomy and its legacy. Eur Urol 47: 22-28.
24. Kim SC, Kuo RL, Lingeman JE (2003) Percutaneous nephrolithotomy: an
update. urr Opin Urol 13: 235-241.
25. Srivastava A, Singh KJ, Suri A, Dubey D, Kumar A, et al. (2005) Vascular
complications aer percutaneous nephrolithotomy: are there any
predictive factors? Urology 66: 38-40.
26. El-Nahas AR, Shokeir AA, El-Assmy AM, Mohsen T, Shoma AM, et al.
(2007) Post-percutaneous nephrolithotomy extensive hemorrhage: a
study of risk factors. J Urol 177: 576-579.
27. Srivastava A, Singh KJ, Suri A, Dubey D, Kumar A, et al. (2005) Vascular
complications aer percutaneous nephrolithotomy: are there any
predictive factors? Urology 66: 38-40.
28. El-Nahas AR, Shokeir AA, Mohsen T, Gad H, El-Assmy AM, et al. (2008)
Functional and morphological eects of post percutaneous
nephrolithotomy super selective renal angiographic embolization.
Urology 71: 408-412.
Citation: Valecha NK, Bagheri F, Hassani S, Sadi A, Souliman R (2017) Delayed Haematuria after Percutaneous Nephrolithotripsy and its
Management. Med Sur Urol 6: 189. doi:10.4172/2168-9857.1000189
Page 4 of 5
Med Sur Urol, an open access journal
ISSN:2168-9857
Volume 6 • Issue 3 • 1000189
29. Poulakis V, Ferakis N, Becht E, Deliveliotis C, Duex M (2006) Treatment
of renal-vascular injury by transcatheter embolization: immediate and
long-term eects on renal function. J Endourol 20: 405-409.
30. Sacha K, Szewczyk W, Bar K (1996) Massive haemorrhage presenting as a
complication aer percutaneous nephrolithotomy (PCNL). Int Urol
Nephrol 28: 315-318.
31. Kessaris DN, Bellman GC, Pardalidis NP, Smith AG (1995) Management
of hemorrhage aer percutaneous renal surgery. J Urol 153: 604-608.
32. Cope C, Zeit RM (1982) Pseudoaneurysms aer nephrostomy. AJR Am J
Roentgenol 139: 255-261.
33. Wen-Hong Huang, et al. (2003) Risk Factors of Massive Bleeding Aer
Percutaneous Nephrolithotomy and its Management. JTUA 14: 65-70.
34. Keoghane SR, Cetti RJ, Rogers AN, Walmsley BH, (2012) Blood
transfusion, embolization and nephrectomy aer percutaneous
nephrolithotomy (PCNL). BJU International 111: 628-632.
35. Kessaris DN, Bellman GC, Pardalidis NP, Smith AG (1995) Management
of hemorrhage aer percutaneous renal surgery. J Urol 153: 604-608.
36. Kernohan RM, Johnston LC, Donaldson RA (1990) Bleeding following
percutaneous nephrolithotomy resulting in loss of the kidney. Br J Urol
65: 657-658.
37. Shahzad Ali, Naresh Kumar and Umer Baloch (2014) Outcome of
Percutaneous Nephrolithotomy. Journal of the College of Physicians and
Surgeons Pakistan 24: 261-264.
38. Patterson DE, Segura JW, Leroy AJ, Benson RC, May G, et al. (1985) e
etiology and treatment of delayed bleeding following percutaneous
lithotripsy. J Urol 133: 447-451.
Citation: Valecha NK, Bagheri F, Hassani S, Sadi A, Souliman R (2017) Delayed Haematuria after Percutaneous Nephrolithotripsy and its
Management. Med Sur Urol 6: 189. doi:10.4172/2168-9857.1000189
Page 5 of 5
Med Sur Urol, an open access journal
ISSN:2168-9857
Volume 6 • Issue 3 • 1000189
... При этом следует отметить, что в настоящее время назначение пери-и послеоперационной антибиотикотерапии, на наш взгляд, является целесообразным для всех пациентов при проведении ЧНЛТ вне зависимости от выраженности лихорадки для профилактики гнойно-воспалительных осложнений. Гематурия после ЧНЛТ, ранняя или отсроченная, является одним из самых распространенных осложнений, которое в большинстве случаев успешно лечится консервативными методами (постельный режим, удаление сгустков крови при их наличии, внутривенное введение жидкости, а также антибактериальная терапия [29]). Однако 0,4-2% пациентов требуют проведения ранней или срочной цифровой субтракционной ангиографии (ЦСА) и транскатетерной ангиоэмболизации (ТАЭ) для остановки обильного и прерывистого кровотечения вследствие неэффективности консервативных методов [30]. ...
Article
Full-text available
Kidney stone disease (KSD) is a disease caused by the formation of calculi in kidneys and other parts of the urinary tract. The rate of hospitalization of children with KSD worldwide is increasing. The adequate method of calculus extraction and further therapy according to calculus composition and metabolic disorders are crucial for effective treatment of patients with KSD and recurrence risk reduction. This review covers surgical (extracorporeal lithotripsy, percutaneous nephrolithotripsy, retrograde intrarenal surgery, ureterolithotripsy, laparoscopy, open surgery) and non-surgical (lithokinetic and litholytic) therapy. Special attention is paid to metaphylaxis, or recurrence prevention, and calculi formation. It is noted that medication of children with KSD can be aggravated by various adverse reactions, complexity in drugs dosages in children of first years of life. Moreover, all surgical methods are characterized by high risk of postoperative complications development. The relevance of KSD genetic nature in children, the role of lifestyle changes in disease development, the implementation of new drugs for metabolic disorders correction are presented in the article.
Article
Full-text available
Introduction: the study aims to match different volumes of nephrostomy balloon inflation to point out the foremost effective volume size of post percutaneous nephrolithotomy (PCNL) bleeding control. Methods: we have retrospectively reviewed "560" medical records of patients who underwent percutaneous nephrolithotomy between (the years 2017 and 2018) at Prince Hussein Urology Center. The Patients were divided into two teams, group-1 (a number of 280 patients) with nephrostomy balloon inflated concerning three ml and group-2 (a number of 280 patients) the balloon inflated concerning one ml. The preoperative and postoperative hematocrit, the operation duration, the stone size, the postoperative pain severity, the transfusion rate and the duration of hematuria between the two groups were compared during hospitalization. Results: regarding patients with ages (between 18 and 68 years); the preoperative hematocrit (mean values ± SDs) was (40.35% ± 3.57) vs (39.95% ± 3.43) for groups-1 and 2, respectively; the p value=0.066. The postoperative hematocrit was (37.91% ± 3.96) vs (34.38 ± 2.78), respectively; the p value was (0.008); the blood transfusion rate was 11.2% vs 13.4% (the p value was 0.039), respectively. The Postoperative pain score was (4.93 ± 1.44) vs (3.89 ± 1.45) (the p value was 0.012), respectively. Conclusion: increasing the nephrostomy balloon volume to a "3cc" competes for a task to decrease bleeding which was found to be as a secure and considerable effective procedure-related factor. However, the disadvantage of this technique resulted in increasing the postoperative pain in patients undergoing such a procedure.
Article
Full-text available
Main findings: We describe the use of a novel endoscopic approach in the management of unremitting gross hematuria following post-percutaneous nephrolithotomy (PCNL) in a 65-years-old male. This approach proved successful and cost-effective in managing haemorrhage post-PCNL when renal angiography failed to localize the source of bleeding. Case hypothesis: The recommended treatment modality for renal calculi ≥ 2cm is PCNL. It is essential that clinicians are aware of the various complications that can arise from PCNL, including arteriovenous fistula, which is typically managed with renal angio--embolization. The development of a renal arteriopelvic fistula (APF) is an extremely rare complication, and accounts of haemorrhage from renal APF and its treatment have not been well-described in the literature. We successfully hypothesized that the ureteroscopic localization, fulguration, and closure with a fibrin sealant at the site of the arterial bleed results in optimal treatment for this clinical presentation. We report this case in detail. Promising Future Implications: The successful and cost-effective endoscopic approach described here for treatment of post-PCNL renal APF and unremitting gross hematuria ought to be considered as an adjunct to renal angiography and embolization when the source of bleeding cannot be accurately identified using traditional imaging modalities.
Article
Objective: To assess the implementation of Percutaneous Nephrolithotomy (PCNL) in renal stone management and evaluate the factors for efficacy and safety of PCNL. Study design: Case series. Place and duration of study: Department of Urology at Jinnah Postgraduate Medical Centre, Karachi, from January 2008 to December 2011. Methodology: Patients aged above 12 years of age, irrespective of gender with normal renal function, mean stone size > 2 cm, lower pole stones > 1 cm, and ESWL failure were selected. After the procedure, on the first postoperative day, a plain abdominal radiograph was obtained to verify stone clearance. A nephrostomy tube was clamped overnight and subsequently removed when no residual stone which needs second sitting was seen. Results: In 175 patients, 62.86% (n=110) were male and the mean age was 35 ± 9.56 years. One hundred and seventeen (66.85%) patients were primarily stone free and 13.71% (n=24) patients needed a second look procedure, thus, a total of 80.57% (n=141) patients were stone free in the same admission. Complications included failure in 4.0% (n=7) patients, bleeding in 8.57% (n=15) patients, a small residual stone in 15.43% (n=27) patients; and puncture site pain almost in every patient. Transient fever occurred in 55.43% (n=97) patients, urinary leakage in 8.57% (n=15) patients, urinary tract infections in 5.14% (n=9) patients, ureteric colic in 3.43% (n=6) patients, colonic injury in 0.57% (n=1) patient; and nephrectomy was required in 0.57% (n=1) patient due to severe bleeding. One patient (0.57%) expired due to anaesthesia complications. Conclusion: Percutaneous nephrolithotomy (PCNL) has a good success rate. There is minimal blood loss, and few major complications.
Article
Percutaneous nephrolithotomy (PCNL) revolutionized stone surgery decades ago. However, it is still a challenging surgical technique that requires professional preparation and knowledge of possible problems and their solutions.We illuminate the recent literature on indications for PCNL, preoperative diagnostics, required patient preparation, and the different techniques of the whole procedure, including positioning the patient, gaining access to the collecting system, disintegrating the stone, and finishing the operation. All up-to-date discussions are included. Recognition and handling of possible complications are described in detail.PCNL is one of the most powerful instruments of the urologist for stone treatment. In an expert's hands, the procedure is gentle, fast, and efficient. To become an expert, continuous training with supervision is necessary. However, further development of instruments and techniques enables surgeons to perform more complex cases and to broaden the indications. To gain a successful performance, exact exploration and preparation of the patient is decisive. In the rare case of severe complications, a well-trained team of nurses, radiologists, and anesthesiologists is priceless.
Article
Introduction: Percutaneous nephrolithotomy (PCNL) represents a safe and efficient procedure in the surgical management of renal lithiasis. Nevertheless, surgeons have to face specific complications during and after the procedure, hemorrhage being one of the most common. In most cases the injuries are self-limited and do not need a surgical intervention. Renal arteriography with selective angiographic embolization is needed in patients with massive hemorrhage or continuous hematuria. Our objective was to evaluate the effectiveness of percutaneous transarterial embolization for the treatment of renal arterial post-PCNL bleeding. Material and method: This retrospective study was performed between March 2007 and October 2012 and included 22 patients who had undergone renal embolization due to significant post-PCNL renal artery bleeding. The site, number, and type of bleeding lesions, and the result of the embolization procedure were recorded. We report on the incidence, treatment, radiological and clinical results of these serious vascular injuries at our institution. Results: Our study has included a large group of patients, the 95.45% angiographic success rate confirming that percutaneous transcatheter embolization is a valuable treatment for most renal vascular injuries. Renal angiography revealed pseudoaneurysm in 15 patients, arteriovenous fistula in 5 and arterial laceration in 2 patients. Significant risk factors on univariate analysis for severe hematuria requiring superselective angiography were multiple staghorn calculi, upper calix puncture and history of pyelonephritis. The severity of the hematuria after PCNL is influenced by many factors, including mean stone size and mean operative time and is correlated with duration of hospitalization and mean hemoglobin drop. Conclusions: Percutaneous transarterial embolization of the injured vessel is an effective, minimally invasive and relatively easy procedure in experienced centers, with high rate of success and immediate benefits, thus saving the patient from the morbidity that results from severe renal bleeding.
Article
There is still an ongoing debate regarding the optimal endourological treatment of upper urinary tract lithiasis, a significant parameter being the stone free rate. However, despite the apparent simplicity of notions such as stone free or success rate, when analyzing the available literature one may discover the complex, intricate and debatable issues behind them. The main problems reside in the heterogeneous way of defining intervention success, the timing at which a patient is considered stone-free and also in the lack of standard postoperative evaluation of patients with urolithiasis. A review of the literature in regard of these notions was performed, in order to identify methods to improve the standardization of these notions.
Article
Unlabelled: WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Percutaneous treatment for renal stone disease is associated with a risk of significant morbidity. Our large UK series provides contemporary data on the risk of vascular complications and admission to the Intensive Care Unit (ICU) after PCNL. When compared with recent international databases, these data support the current evidence that better outcomes can be achieved in centres performing large numbers of procedures. These data add to the debate for the centralisation of specialist stone surgery. Objective: To audit the outcome of percutaneous nephrolithotomy (PCNL) at a UK stone centre over a 10-year period, and provide patients with understandable contemporary data on blood loss and vascular risk. Patients and methods: A single centre retrospective analysis of all PCNLs undertaken between April 2000 and December 2010. The association between transfusion and patient age, operative duration and positive preoperative mid-stream urine (MSU) sample was subject to statistical analysis. Results: Data on 568 patients was analysed. 21 were paediatric cases with a mean (range) age of 8 (2-16) years; 547 were adult cases with a mean (range) age of 55 (17-84) years. 3.8% of adult patients (21/547) received a blood transfusion; mean age 60 years (55 years in those not transfused) with a mean operative duration of 119 min (103 min in those not transfused). 23.8% of patients transfused had a confirmed preoperative urinary tract infection compared with 16.1% of those not transfused. Seven patients underwent angiography, with five having selective arterial embolisation (0.9%). There were no deaths in this series although one patient (0.2%) required an urgent nephrectomy due to cardiovascular instability from bleeding. Conclusions: Large UK series that provides contemporary data for consent on vascular risk at PCNL. The risk of transfusion is associated with increased patient age, operative duration and the presence of a positive preoperative MSU sample. Data compares favourably with other large published series, and supports the argument for centralisation of percutaneous stone management.